Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
NCLT DBS Bank Order
April 11, 2026
Certificate under Reg 74(5) of DP Regulation for March qtr
April 9, 2026
Trading window closure_March 2026
March 27, 2026
Update Relating to Scheme of Amalgamation - Order Reservation
March 18, 2026
Outcome of BM_February 11, 2026
February 11, 2026
Monitoring Agency Report_Q3_December 31, 2025
February 11, 2026
Prior intimation of Board Meeting_February 2026
February 6, 2026
Integrated Governance Report_December 31, 2025
January 28, 2026
Reconciliation of Share Capital_December 31, 2025
January 24, 2026
Certificate under Reg 74(5) of DP Regulation_December 31, 2025
January 8, 2026
Trading Window Closure_December, 2025
December 29, 2025
Monitoring Agency Report_Q2_September 30, 2025
November 13, 2025
Outcome of BM_November 11, 2025
November 11, 2025
Prior intimation of Board Meeting_November 2025
November 5, 2025
Reply Letter on query for Volume Movement of Securities - BSE
November 4, 2025
Reply Letter on query for Volume Movement of Securities - NSE
November 4, 2025
1
...
Next
1 / 36